It was found that Sef expression is downregulated in essentially every carcinoma type examined thus far including breast, thyroid, ovarian, colon and prostate cancers, in a manner correlating with tumor aggressiveness20–22. The gene discussed is IL17RD; the disease is prostate carcinoma.